Expediting Drug Development: Use of ctDNA as an Early Endpoint

preview_player
Показать описание
00:00 - Meeting Begins
03:06 - Fireside Chat with Patrizia Cavazzoni and Ellen Sigal
19:53 - Panel 1: Leveraging Learnings from Recent Endpoint Validation Studies
42:40 - Panel 2: Developing an Evidentiary Roadmap for Use of ctDNA
  1. Friends of Cancer Research
Рекомендации по теме
Expediting Drug Development: 1:25:24

Expediting Drug Development: Use of ctDNA as an Early Endpoint

Deep dive into 0:04:44

Deep dive into FDA’s expedited programs for drug development

Expedited Programs for 0:07:25

Expedited Programs for Drug Approvals

Rapid Formulation Development 0:07:01

Rapid Formulation Development and Clinical Testing – Expediting Development of Optimal Drug Products...

CMC001 - Expedited 0:19:12

CMC001 - Expedited Drug Development - James Mencel

FDA Expedited Program 0:01:30

FDA Expedited Program for Drug Development Webinar

FDA’s Expedited Development 0:55:45

FDA’s Expedited Development and Approval Programs

FDA Expedited Programs 0:02:26

FDA Expedited Programs

Understanding the FDA's 0:14:50

Understanding the FDA's Breakthrough Therapy Designation

22 Reduce 0:01:55

22 Reduce drug development costs, expedite drug development

Expedited regulatory pathways 0:48:29

Expedited regulatory pathways

Understanding FDA Expedited 0:04:43

Understanding FDA Expedited Programs 📋

Enabling expedited review 0:01:07

Enabling expedited review programs webinar trailer

Effectively Navigating FDA 0:02:55

Effectively Navigating FDA Expedited Programs

ACT 2024—Nonclinical Safety 0:03:34

ACT 2024—Nonclinical Safety Evaluation Findings to Expedite Next-Generation GLP-1RAs Development

FDA Product Regulations 0:09:16

FDA Product Regulations Part 4 of 7

Friends of Cancer 0:59:32

Friends of Cancer Research Annual Meeting Day 1: Modernizing Expedited Approval Programs

Expedited US FDA 0:56:50

Expedited US FDA Development and Approval Programs for Serious Conditions

'Expediting Access to 0:29:46

'Expediting Access to a Promising New ALS Drug…'

Why it's important 0:01:37

Why it's important to expand the use of expedited regulatory pathways and how should we do it?

ASK AN ALTASCIENTIST 0:03:14

ASK AN ALTASCIENTIST | Expediting the Processing Time for CITES Permits

Mighty metals: Probing 0:45:02

Mighty metals: Probing nuclear waste and expediting drug discovery

Expediting the Medical 0:31:09

Expediting the Medical Writing Process

Orphan Drug, Rare 0:01:45

Orphan Drug, Rare Pediatric Disease, and Expedited Program Designations Webinar (10/6)